Short-term effect of IL-6 inhibition in spondylarthritis

Joint Bone Spine. 2010 Dec;77(6):624-5. doi: 10.1016/j.jbspin.2010.09.011. Epub 2010 Oct 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • C-Reactive Protein / analysis
  • Disability Evaluation
  • Humans
  • Interleukin-6 / antagonists & inhibitors*
  • Magnetic Resonance Imaging
  • Male
  • Recovery of Function
  • Severity of Illness Index
  • Spondylarthritis / drug therapy*
  • Spondylarthritis / pathology
  • Spondylarthritis / physiopathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • IL6 protein, human
  • Interleukin-6
  • C-Reactive Protein
  • tocilizumab